ProShare Advisors LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$30,079
-10.2%
17,488
+1.9%
0.00%
Q2 2023$33,477
-46.0%
17,168
+14.1%
0.00%
Q1 2022$62,000
-74.5%
15,041
-20.5%
0.00%
Q4 2021$243,000
+153.1%
18,912
+80.5%
0.00%
Q2 2021$96,000
-4.0%
10,476
-5.8%
0.00%
Q4 2019$100,00011,1210.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$41,970,0008.18%
Copernicus Capital Management, LLC 37,000$349,0005.64%
EcoR1 Capital, LLC 3,421,287$32,263,0001.43%
Palo Alto Investors LP 2,298,382$21,674,0001.24%
AlpInvest Partners B.V. 226,866$2,139,0001.06%
Stenahm Asset Managment Ltd 150,000$1,415,0001.00%
FRAZIER MANAGEMENT LLC 1,030,878$9,721,0000.78%
BVF INC/IL 1,861,239$17,551,0000.66%
Avidity Partners Management LP 2,122,064$20,011,0000.55%
Redmile Group, LLC 2,448,158$23,086,0000.32%
View complete list of GRITSTONE ONCOLOGY INC shareholders